Active Ownership Capital by mutual agreement with the

DGAP-Media / 13.05.2016 / 10:05

Active Ownership Capital by mutual agreement with the chairman of the
Supervisory Board of STADA Arzneimittel AG Dr. Martin Abend clarifies
supplementary motion for the agenda of 2016 AGM: Replacement of three
Supervisory Board members and abolition of transfer restrictions for
registered Shares

- Clarified wording of proposed resolutions represents good compromise
between strengthening the Supervisory Board with broader and more relevant
expertise and ensuring continuity in the Supervisory Board in the interest
of the company

- Proposal for reclassification of registered shares with restricted
transferability to registered shares remains

- Active Ownership Capital sees strengthened Supervisory Board as a first
major step to developing the company further together with management

Luxembourg/Bad Vilbel, May 13, 2016 - Active Ownership Capital, an
independent, partner-managed investment company, today announced that by
mutual agreement with the chairman of the Supervisory Board of STADA
Arzneimittel AG Dr. Martin Abend it has clarified the wording of the
proposed resolutions in its supplementary motion for the agenda of the
Annual General Meeting of STADA Arzneimittel AG (ISIN DE0007251803) on June
9, 2016.

According to the refined supplementary motion, Active Ownership Capital
proposes the replacement of three of the nine Supervisory Board members.
The candidates to be appointed include two independent nominees and one
representative of Active Ownership Capital, to which more than 5% of the
STADA shares are attributed to. The proposed candidates have confirmed
their willingness to join the Supervisory Board of STADA Arzneimittel AG in
case of their election.

- Klaus-Joachim Krauth (born 1961) - Former CFO of HEXAL and Athos; expert
for the healthcare industry and finance; extensive experience in generics
and branded products

- Klaus Röhrig (born 1977) - Founding Partner Active Ownership Capital;
extensive investment, value creation and corporate governance experience

- Dr. Ulrich Wandschneider (born 1961) - CEO of Asklepios Kliniken until
April 2016; former Director of Healthcare Consulting at Arthur Andersen;
expert on tax law and healthcare Management

Active Ownership Capital continues to propose the reclassification of
registered shares with restricted transferability to registered shares.
Active Ownership Capital considers the limitation of rights of shareholders
by management as outdated and inappropriate.

Active Ownership Capital has issued the following statement in this regard:

"The goal of our clarified resolution proposal is to renew the Supervisory
Board of STADA and strengthen it with internationally renowned experts.
Active Ownership Capital firmly believes that the proposed candidates for
the Supervisory Board are ideally qualified to meet the challenges of STADA
today and in the future. In our view, STADA has a high value creation
potential. A strengthened Supervisory Board is a first major step to
developing the company further together with the management."

Further information, detailed resumes of the proposed candidates and a
presentation on the supplementary motion of Active Ownership Capital are
available on the following website: www.saz-governance.de

Shareholders of STADA Arzneimittel AG who wish to support the proposals of
Active Ownership Capital, can grant voting proxy rights for the Annual
General Meeting of STADA Arzneimittel AG on June 9, 2016 at no charge. A
corresponding form will be available as of May 16 2016 at the website
www.saz-governance.de

# # #

About Active Ownership Capital

Active Ownership Capital is an independent, partner-managed investment
company which acquires significant minority stakes in publicly listed,
undervalued small- and mid-size companies in German speaking countries
(Germany, Switzerland, Austria) and the Nordics (Sweden, Finland, Denmark,
Norway). Active Ownership Capital follows an active ownership approach and
fosters value creation through operational, strategic and structural
improvements.

For us, active ownership means that we act as the company's partner and
support it long-term. Together with management, we define value-enhancing
strategies and measures and are ready to support their implementation as
supervisory board members and advisors. As equity investors we add
long-term oriented entrepreneurial thinking to publicly listed companies.
Our investor base consists of European family offices and selected
institutional investors.


PRESS CONTACT

Charles Barker Corporate Communications GmbH
KORNELIA SPODZIEJA 
kornelia.spodzieja@charlesbarker.de 
Tel: +49 69 79409040
Mobile: +49 172 622 7007

TOBIAS EBERLE
tobias.eberle@charlesbarker.de
Tel: +49 69 79409024
Mobile: +49 173 520 4436


End of Media Release

---------------------------------------------------------------------------

Issuer: Active Ownership Capital S.à r.l.
Key word(s): Finance

13.05.2016 Dissemination of a Press Release, transmitted by DGAP - a service
of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------

463557 13.05.2016
Active Ownership Capital by mutual agreement with the chairman of the Supervisory Board of STADA Arzneimittel AG Dr. Martin Abend clarifies supplementary motion for the agenda of 2016 AGM
